RECRUITING

An Acupuncture Study for People At High Risk for Sepsis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Researchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sham acupuncture. Sham acupuncture is performed the same way as real acupuncture but will use different needles and target different sites or places on the body than real acupuncture.

Official Title

Acupuncture to Improve Outcomes in Sepsis Patient: The ACTIONS Trial

Quick Facts

Study Start:2024-03-20
Study Completion:2028-03-20
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06344819

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 or older
  2. * Having MSK sepsis order-set placed within the previous 48 hours
  1. * The study Principal Investigator will review the medical record again prior to enrollment to exclude non-sepsis patients (Even though the placement of sepsis order set already screens out such patients, subsequent clinical development after sepsis order set placement may generate new information that deems the patient not septic.)
  2. * Admitted to ICU before being approached for consenting
  3. * Having an implanted medical device, such as a pacemaker or implantable cardioverter-defibrillator (ICD), with which electroacupuncture
  4. * Unable to obtain informed consent due to a participant's mental status and absence of an individual authorized to give consent on the participant's behalf
  5. * The patient is on an interventional clinical trial and its Principal Investigator does not give approval to enrollment to this study (e.g. genomic profiling, biospecimen, or observational studies do not require PI approval).

Contacts and Locations

Study Contact

Gary Deng, MD, PhD
CONTACT
646-608-8556
dengg@mskcc.org
Jun Mao, MD, MSCE
CONTACT
646-608-8552
maoj@mskcc.org

Principal Investigator

Gary Deng, MD, PhD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Gary Deng, MD, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-20
Study Completion Date2028-03-20

Study Record Updates

Study Start Date2024-03-20
Study Completion Date2028-03-20

Terms related to this study

Keywords Provided by Researchers

  • sepsis
  • acupuncture
  • Memorial Sloan Kettering Cancer Center
  • 24-062

Additional Relevant MeSH Terms

  • Sepsis